endpoints.news
is our new home on June 1. endpts.com will still work, but the front door is now
https://endpoints.news
Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Embattled Harvard scientist Charles Lieber goes on a counter-offensive, hiring high-profile lawyer and suing Harvard for abandoning him amid federal probe
5 years ago
Sami Anwar raked in millions of dollars gathering drug trial data at his sites. But it was all a lie — and now he's been sentenced to 28 years
5 years ago
Pharma
BARDA chief turned whistleblower Rick Bright resigns from government with one last broadside against the Trump administration
5 years ago
Coronavirus
Emmanuelle Charpentier and Jennifer Doudna win the Nobel Prize for groundbreaking CRISPR discovery
5 years ago
R&D
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
5 years ago
Startups
Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart
5 years ago
Financing
Harvard 'MacArthur genius’ Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin
5 years ago
R&D
Three scientists win Nobel Prize in Medicine for work in discovering hepatitis C virus
5 years ago
Discovery
Two top execs in Sanofi's R&D group are hitting the exit in a shakeup as Frank Nestle moves up to CSO
5 years ago
Merck R&D chief Roger Perlmutter is handing off the big job to the exec in charge of discovery
5 years ago
R&D
C4's Andrew Hirsch blows up IPO to $182M, while oncolytic virus upstart nabs $87M offering
5 years ago
Financing
R&D
With a potential FDA approval looming, G1 Therapeutics taps ex-GSK US president Jack Bailey as new CEO
5 years ago
R&D
A second Carl Icahn protégé jumps in on SPAC spree, as Alex Denner guns for $175M
5 years ago
Financing
Merck's Roger Perlmutter makes a rare move, joining the board of a machine learning startup out to change the R&D world. And he has some thoughts on that
5 years ago
AI
Jeffrey Bluestone recruits a trio of biopharma vets to the startup team at Sonoma — while adding $30M to the launch round
5 years ago
Financing
Black Diamond brings in ex-GSK CEO Bob Ingram to chart new path in precision oncology
5 years ago
Belén Garijo rises to the top at Merck KGaA amid exec board makeover
5 years ago
Chair of FDA's vaccine adcomm — who's also a lead investigator of Moderna's vaccine — recuses herself from Covid-19 talks
5 years ago
Coronavirus
Flagship's merged biotech Repertoire nets ex-Pfizer CSO Anthony Coyle as R&D chief
5 years ago
R&D
Rocked by customs investigation, Legend's CFO takes over as CEO Frank Zhang placed under house arrest
5 years ago
China
Cell/Gene Tx
A micro-cap with a potentially promising coronavirus drug enlists mask-skeptic congressman for DSMB
5 years ago
Coronavirus
A longtime CytomX exec re-emerges at Synthekine, an $82M Stanford spinout
5 years ago
Financing
Cell/Gene Tx
Sean Bohen's break from biopharma is over. The ex-AstraZeneca CMO has retired his Big Pharma jersey and is now — happily — running a little biotech
5 years ago
Bioregnum
Opinion
After leading Celgene buyout, Matthew Roden leaves Bristol Myers Squibb for venture capital firm
5 years ago
First page
Previous page
65
66
67
68
69
70
71
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit